Lapatinib CAS 231277-92-2 for Anti-Cancer Raw Powder Pharma

Lapatinib CAS 231277-92-2 for Anti-Cancer Raw Powder Pharma Grade

Email:kathelin@yccreate.com
Skype:live:kathelin_4
WhatsApp:+86-188 7222 0706

1.Lapatinib  is a breast cancer targeted therapy drug . Breast cancer molecular targeted therapy aims at the occurrence and development of cancer-related genes and their expression products of breast cancer for treatment. Molecular targeted drugs by blocking signal transduction of tumor cells or associated cells , control changes in cell gene expression, in order to inhibit or kill tumor cells.

2.Lapatinib is a novel targeted anti-cancer drug. It Can act on Her-1 and Her-2 two targets at he same time, the biological effect of the inhibition of tumor cell proliferation and growth arising from this mode of action is much larger than acting on just one target. The so-called targeted therapy, refers to certain receptors, genes or proteins as a key target, and then targets to kill tumor cells related to drugs.